FEATURED COMPANIES
- CMIC Co. Ltd
- Covance Inc.
- ICON Plc
- IQVIA Holdings Inc.
- Novotech Pty Ltd
- PRA Health Sciences Inc.
The European pharmaceutical CRO market accounted for $11.96 billion in 2019 and will grow by 7.9% annually over 2020-2030 owing to the rising incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 36 tables and 45 figures, this 113-page report “Europe Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe pharmaceutical CRO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies of the period 2015-2019 and provides a forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Based on Service, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe pharmaceutical CRO market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Highlighted with 36 tables and 45 figures, this 113-page report “Europe Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe pharmaceutical CRO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies of the period 2015-2019 and provides a forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Service, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
- CRO for Pre-clinical Development
- CRO for Phase I Trials
- CRO for Phase II Trials
- CRO for Phase III Trials
- CRO for Phase IV Trials
- Laboratory Services
- Consulting Services
- Data Management Services
- Infectious Diseases
- Oncology
- Metabolic Disorders
- Cardiovascular Disorders
- Central Nervous System
- Respiratory Disorders
- Gastrointestinal Disorders
- Other Therapeutic Applications
- Pharmaceutical & Biopharmaceutical Companies
- Medical Device Companies
- Academic Institutes
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Rest of Europe (further segmented into Netherlands, Switzerland, Turkey, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe pharmaceutical CRO market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
- Charles River Laboratories
- CMIC Co. Ltd
- Covance Inc.
- Hangzhou Tigermed Consulting Co Ltd
- ICON Plc
- IQVIA Holdings Inc.
- LSK Europe Pharma Service Co Ltd
- Novotech Pty Ltd
- PAREXEL International Corporation
- Pharmaceutical Product Development LLC (PPD)
- PRA Health Sciences Inc.
- Quanticate Ltd
- Samsung Bioepis Co. Ltd
- SGS SA (SGS Life Sciences)
- Syneos Health Inc.
- WuXi AppTec Inc.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- CMIC Co. Ltd
- Covance Inc.
- ICON Plc
- IQVIA Holdings Inc.
- Novotech Pty Ltd
- PRA Health Sciences Inc.
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 Segmentation of Europe Market by Service
3.1 Market Overview by Service
3.2 CRO for Pre-clinical Development
3.3 CRO for Phase I Trials
3.4 CRO for Phase II Trials
3.5 CRO for Phase III Trials
3.6 CRO for Phase IV Trials
3.7 Laboratory Services
3.8 Consulting Services
3.9 Data Management Services
4 Segmentation of Europe Market by Therapeutic Application
4.1 Market Overview by Therapeutic Application
4.2 Infectious Diseases
4.3 Oncology
4.4 Metabolic Disorders
4.5 Cardiovascular Disorders
4.6 Central Nervous System
4.7 Respiratory Disorders
4.8 Gastrointestinal Disorders
4.9 Other Therapeutic Applications
5 Segmentation of Europe Market by End User
5.1 Market Overview by End User
5.2 Pharmaceutical & Biopharmaceutical Companies
5.3 Medical Device Companies
5.4 Academic Institutes
6 European Market 2019-2030 by Country
6.1 Overview of European Market
6.2 Germany
6.3 UK
6.4 France
6.5 Spain
6.6 Italy
6.7 Russia
6.8 Rest of European Market
7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
8.1 Risk Evaluation of Europe Market
8.2 Critical Success Factors (CSFs)
List of Tables
Table 1. Snapshot of Europe Pharmaceutical CRO Market in Balanced Perspective, 2019-2030
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. Worldwide Total Number of Registered Clinical Trials
Table 5. Main Product Trends and Market Opportunities in Europe Pharmaceutical CRO Market
Table 6. Europe Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 7. Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 8. Europe Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 9. Europe Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 10. Germany Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 11. Germany Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 12. Germany Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 13. UK Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 14. UK Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 15. UK Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 16. France Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 17. France Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 18. France Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 19. Spain Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 20. Spain Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 21. Spain Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 22. Italy Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 23. Italy Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 24. Italy Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 25. Russia Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 26. Russia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 27. Russia Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 28. Pharmaceutical CRO Market in Rest of Europe by Country, 2019-2030, $ bn
Table 29. Breakdown of Europe Market by Key Vendor, 2019, %
Table 30. Charles River Laboratories: Company Snapshot
Table 31. Charles River Laboratories: Business Segmentation
Table 32. Charles River Laboratories: Product Portfolio
Table 33. Charles River Laboratories: Revenue, 2016-2018, $ bn
Table 34. Charles River Laboratories: Recent Developments
Table 35. Risk Evaluation for Investing in Europe Market, 2019-2030
Table 36. Critical Success Factors and Key Takeaways
List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Europe Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Europe Pharmaceutical CRO Market
Figure 8. Primary Restraints and Impact Factors of Europe Pharmaceutical CRO Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Europe Pharmaceutical CRO Market
Figure 11. Breakdown of Europe Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue
Figure 12. Europe Addressable Market Cap in 2020-2030 by Service, Value ($ bn) and Share (%)
Figure 13. Europe Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn
Figure 14. Europe Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn
Figure 15. Europe Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn
Figure 16. Europe Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn
Figure 17. Europe Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn
Figure 18. Europe Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn
Figure 19. Europe Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn
Figure 20. Europe Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn
Figure 21. Breakdown of Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue
Figure 22. Europe Addressable Market Cap in 2020-2030 by Therapeutic Application, Value ($ bn) and Share (%)
Figure 23. Europe Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn
Figure 24. Europe Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn
Figure 25. Europe Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn
Figure 26. Europe Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn
Figure 27. Europe Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn
Figure 28. Europe Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn
Figure 29. Europe Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn
Figure 30. Europe Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn
Figure 31. Breakdown of Europe Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue
Figure 32. Europe Addressable Market Cap in 2020-2030 by End User, Value ($ bn) and Share (%)
Figure 33. Europe Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn
Figure 34. Europe Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn
Figure 35. Europe Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn
Figure 36. Breakdown of European Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue
Figure 37. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 38. Pharmaceutical CRO Market in Germany, 2019-2030, $ bn
Figure 39. Pharmaceutical CRO Market in UK, 2019-2030, $ bn
Figure 40. Pharmaceutical CRO Market in France, 2019-2030, $ bn
Figure 41. Pharmaceutical CRO Market in Spain, 2019-2030, $ bn
Figure 42. Pharmaceutical CRO Market in Italy, 2019-2030, $ bn
Figure 43. Pharmaceutical CRO Market in Russia, 2019-2030, $ bn
Figure 44. Pharmaceutical CRO Market in Rest of Europe, 2019-2030, $ bn
Figure 45. Growth Stage of Europe Pharmaceutical CRO Industry over the Forecast Period
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 Segmentation of Europe Market by Service
3.1 Market Overview by Service
3.2 CRO for Pre-clinical Development
3.3 CRO for Phase I Trials
3.4 CRO for Phase II Trials
3.5 CRO for Phase III Trials
3.6 CRO for Phase IV Trials
3.7 Laboratory Services
3.8 Consulting Services
3.9 Data Management Services
4 Segmentation of Europe Market by Therapeutic Application
4.1 Market Overview by Therapeutic Application
4.2 Infectious Diseases
4.3 Oncology
4.4 Metabolic Disorders
4.5 Cardiovascular Disorders
4.6 Central Nervous System
4.7 Respiratory Disorders
4.8 Gastrointestinal Disorders
4.9 Other Therapeutic Applications
5 Segmentation of Europe Market by End User
5.1 Market Overview by End User
5.2 Pharmaceutical & Biopharmaceutical Companies
5.3 Medical Device Companies
5.4 Academic Institutes
6 European Market 2019-2030 by Country
6.1 Overview of European Market
6.2 Germany
6.3 UK
6.4 France
6.5 Spain
6.6 Italy
6.7 Russia
6.8 Rest of European Market
7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
- Charles River Laboratories
- CMIC Co. Ltd
- Covance Inc.
- Hangzhou Tigermed Consulting Co Ltd
- ICON Plc
- IQVIA Holdings Inc.
- LSK Europe Pharma Service Co Ltd
- Novotech Pty Ltd
- PAREXEL International Corporation
- Pharmaceutical Product Development LLC (PPD)
- PRA Health Sciences Inc.
- Quanticate Ltd
- Samsung Bioepis Co. Ltd
- SGS SA (SGS Life Sciences)
- Syneos Health Inc.
- WuXi AppTec Inc.
8.1 Risk Evaluation of Europe Market
8.2 Critical Success Factors (CSFs)
List of Tables
Table 1. Snapshot of Europe Pharmaceutical CRO Market in Balanced Perspective, 2019-2030
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. Worldwide Total Number of Registered Clinical Trials
Table 5. Main Product Trends and Market Opportunities in Europe Pharmaceutical CRO Market
Table 6. Europe Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 7. Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 8. Europe Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 9. Europe Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 10. Germany Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 11. Germany Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 12. Germany Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 13. UK Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 14. UK Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 15. UK Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 16. France Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 17. France Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 18. France Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 19. Spain Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 20. Spain Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 21. Spain Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 22. Italy Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 23. Italy Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 24. Italy Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 25. Russia Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 26. Russia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 27. Russia Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 28. Pharmaceutical CRO Market in Rest of Europe by Country, 2019-2030, $ bn
Table 29. Breakdown of Europe Market by Key Vendor, 2019, %
Table 30. Charles River Laboratories: Company Snapshot
Table 31. Charles River Laboratories: Business Segmentation
Table 32. Charles River Laboratories: Product Portfolio
Table 33. Charles River Laboratories: Revenue, 2016-2018, $ bn
Table 34. Charles River Laboratories: Recent Developments
Table 35. Risk Evaluation for Investing in Europe Market, 2019-2030
Table 36. Critical Success Factors and Key Takeaways
List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Europe Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Europe Pharmaceutical CRO Market
Figure 8. Primary Restraints and Impact Factors of Europe Pharmaceutical CRO Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Europe Pharmaceutical CRO Market
Figure 11. Breakdown of Europe Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue
Figure 12. Europe Addressable Market Cap in 2020-2030 by Service, Value ($ bn) and Share (%)
Figure 13. Europe Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn
Figure 14. Europe Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn
Figure 15. Europe Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn
Figure 16. Europe Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn
Figure 17. Europe Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn
Figure 18. Europe Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn
Figure 19. Europe Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn
Figure 20. Europe Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn
Figure 21. Breakdown of Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue
Figure 22. Europe Addressable Market Cap in 2020-2030 by Therapeutic Application, Value ($ bn) and Share (%)
Figure 23. Europe Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn
Figure 24. Europe Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn
Figure 25. Europe Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn
Figure 26. Europe Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn
Figure 27. Europe Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn
Figure 28. Europe Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn
Figure 29. Europe Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn
Figure 30. Europe Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn
Figure 31. Breakdown of Europe Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue
Figure 32. Europe Addressable Market Cap in 2020-2030 by End User, Value ($ bn) and Share (%)
Figure 33. Europe Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn
Figure 34. Europe Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn
Figure 35. Europe Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn
Figure 36. Breakdown of European Pharmaceutical CRO Market by Country, 2019 and 2030, % of Revenue
Figure 37. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 38. Pharmaceutical CRO Market in Germany, 2019-2030, $ bn
Figure 39. Pharmaceutical CRO Market in UK, 2019-2030, $ bn
Figure 40. Pharmaceutical CRO Market in France, 2019-2030, $ bn
Figure 41. Pharmaceutical CRO Market in Spain, 2019-2030, $ bn
Figure 42. Pharmaceutical CRO Market in Italy, 2019-2030, $ bn
Figure 43. Pharmaceutical CRO Market in Russia, 2019-2030, $ bn
Figure 44. Pharmaceutical CRO Market in Rest of Europe, 2019-2030, $ bn
Figure 45. Growth Stage of Europe Pharmaceutical CRO Industry over the Forecast Period
Note: Product cover images may vary from those shown
- Charles River Laboratories
- CMIC Co. Ltd
- Covance Inc.
- Hangzhou Tigermed Consulting Co Ltd
- ICON Plc
- IQVIA Holdings Inc.
- LSK Global Pharma Service Co Ltd
- Novotech Pty Ltd
- PAREXEL International Corporation
- Pharmaceutical Product Development LLC (PPD)
- PRA Health Sciences Inc.
- Quanticate Ltd
- Samsung Bioepis Co. Ltd
- SGS SA (SGS Life Sciences)
- Syneos Health Inc.
- WuXi AppTec Inc.
Note: Product cover images may vary from those shown
LOADING...
